Identification of sleep hypoventilation in young individuals with Becker muscular dystrophy: A pilot study
Autor: | Yuko Nakamura, Chika Hosoda, Norika Kubota, Yoshiaki Saito, Takako Ohno, Yoko Nishimura, Yasuko Tokita, Akiko Tamasaki-Kondo, Wataru Matsumura, Yoshihide Sunada, Yoshihiro Maegaki, Masafumi Matsuo, Masuyuki Fukada |
---|---|
Rok vydání: | 2017 |
Předmět: |
musculoskeletal diseases
Adult Male medicine.medical_specialty Vital capacity Adolescent Vital Capacity Pilot Projects Ventricular Function Left Pulmonary function testing Dystrophin 03 medical and health sciences FEV1/FVC ratio Young Adult 0302 clinical medicine Sleep Apnea Syndromes Developmental Neuroscience 030225 pediatrics Internal medicine medicine Humans Respiratory function Muscular dystrophy Creatine Kinase Retrospective Studies Ejection fraction business.industry Retrospective cohort study General Medicine Hypoventilation respiratory system Carbon Dioxide medicine.disease respiratory tract diseases Muscular Dystrophy Duchenne Pediatrics Perinatology and Child Health Cardiology Neurology (clinical) medicine.symptom business Sleep Hypercapnia 030217 neurology & neurosurgery circulatory and respiratory physiology Follow-Up Studies |
Zdroj: | Braindevelopment. 40(7) |
ISSN: | 1872-7131 |
Popis: | Aim To report on sleep hypercapnia in Becker muscular dystrophy (BMD) at earlier stages than ever recognized. Subjects and methods This retrospective study examined nocturnal hypercapnia in six young Becker muscular dystrophy (BMD) patients with deletions of one or more exons of DMD gene. Clinical information, consecutive data on forced vital capacity (FVC%), forced expiratory volume in one second (FEV1%), peak expiratory flow (PEF%), peak cough flow (PCF), average PCO2 in all-night monitoring, and left ventricular ejection fraction (LVEF) were reviewed. Results In five BMD patients, including three who were still ambulant, nocturnal average PCO2 was elevated to >45 mmHg at 12–31 years of age. Noninvasive positive pressure ventilation was initiated in four patients. Gradual declines in FVC% and PEF% were evident in one BMD patient with exon 3–7 deletion, whereas these functions did not change in the remaining BMD patients. PCF, FEV1%, and LVEF were less informative for the assessment of respiratory function in this patient series. Conclusion Sleep hypercapnia was present in certain BMD patients, which was unexpected from the routine pulmonary function tests. Individualized assessment of nocturnal PCO2, partly based on the deletion types, should be further explored in the clinical practice of BMD patients. |
Databáze: | OpenAIRE |
Externí odkaz: |